RHEUMATOLOGY

Despite improvements in therapeutic options, rheumatic diseases remain severe and life-threatening. Patients continue to have active diseases, and adequate treatment of some rheumatic diseases still remains a challenge.

We are well positioned to assist you in developing cost-effective, innovative solutions to challenging study parameters.

Oneiric Internationals Rheumatology clinical trial advantage

  • Capabilities to provide strategic direction with well-trained strategic teams
  • Our clinical team selects sites with dedicated, experienced investigators and appropriate patient population, which is usually a critical task in study execution.
  • Well-developed site network to support efficient and effective patient enrolment.
  • Well-informed and knowledgeable team for successful trial conduct.

At Oneiric Internationals, we are ready to meet all our clients’ study requirements.


Types of Rheumatology Trials:

  • Drug Trials: Investigate the safety and efficacy of new medications for various rheumatological disorders, including rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis, and gout.
  • Biologic and Targeted Therapy Trials: Assess the effectiveness and safety of biologic drugs and targeted therapies designed to modulate specific pathways involved in autoimmune diseases.
  • Interventional Trials: Evaluate specific interventions, such as joint injections, physical therapy, or surgical procedures, for managing symptoms and improving the quality of life.
  • Prevention Trials: Focus on strategies to prevent the development or progression of rheumatological diseases, including studies on early intervention, lifestyle modifications, or novel preventive medications.

Endpoints:

  • Common endpoints in rheumatology trials include improvements in joint pain and swelling, reduction in disease activity, improvement in function and mobility, and overall quality of life.